Page last updated: 2024-11-04

sevoflurane and Lung Injury, Ventilator-Induced

sevoflurane has been researched along with Lung Injury, Ventilator-Induced in 6 studies

Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.

Research Excerpts

ExcerptRelevanceReference
"Desflurane failed to inhibit inflammatory responses and ROS production in lung tissue and developed no antioxidant potential."1.43Inhaled Anesthetics Exert Different Protective Properties in a Mouse Model of Ventilator-Induced Lung Injury. ( Buerkle, H; Engelstaedter, H; Faller, S; Gyllenram, V; Hoetzel, A; Spassov, S; Strosing, KM, 2016)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Müller-Wirtz, LM1
Kiefer, D1
Maurer, F1
Floss, MA1
Doneit, J1
Hüppe, T1
Shopova, T1
Wolf, B1
Sessler, DI1
Volk, T1
Kreuer, S1
Fink, T1
Wagner, J1
Strosing, KM2
Spassov, SG1
Lin, Z1
Engelstaedter, H2
Tacke, S1
Hoetzel, A2
Faller, S2
Yang, Y2
Wang, WF1
Li, YH1
Li, LS1
Guo, X1
Liu, R2
Xiong, XQ1
Lin, LN1
Wang, LR1
Jin, LD1
Li, Y1
Li, J1
Ma, Q1
Zhao, Y1
Wang, D1
Gyllenram, V1
Buerkle, H1
Spassov, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
AnaConDa-therapy in COVID-19 Patients[NCT05586126]42 participants (Actual)Observational2020-10-01Terminated (stopped due to Concerns about possible association between drug and increased ICU mortality)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

6 other studies available for sevoflurane and Lung Injury, Ventilator-Induced

ArticleYear
Volutrauma Increases Exhaled Pentanal in Rats: A Potential Breath Biomarker for Ventilator-Induced Lung Injury.
    Anesthesia and analgesia, 2021, 07-01, Volume: 133, Issue:1

    Topics: Aldehydes; Anesthetics, Inhalation; Animals; Biomarkers; Bronchoalveolar Lavage Fluid; Exhalation; M

2021
Sevoflurane posttreatment prevents oxidative and inflammatory injury in ventilator-induced lung injury.
    PloS one, 2018, Volume: 13, Issue:2

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chemokine CCL4; Disease Models, Anim

2018
Sevoflurane attenuates ventilator‑induced lung injury by regulating c‑PLA2 expression.
    Molecular medicine reports, 2018, Volume: 18, Issue:3

    Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Biopsy; Disease Models, Animal; Female; Gene Ex

2018
Sevoflurane attenuates pulmonary inflammation and ventilator-induced lung injury by upregulation of HO-1 mRNA expression in mice.
    International journal of nanomedicine, 2013, Volume: 6

    Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; He

2013
Effects of sevoflurane on pulmonary cytosolic phospholipase A₂ and clara cell secretory protein expressions in rabbits with one-lung ventilation-induced lung injury.
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2013, Volume: 33, Issue:4

    Topics: Animals; Female; Lung; Male; Methyl Ethers; One-Lung Ventilation; Phospholipases A2; Rabbits; Sevofl

2013
Inhaled Anesthetics Exert Different Protective Properties in a Mouse Model of Ventilator-Induced Lung Injury.
    Anesthesia and analgesia, 2016, Volume: 123, Issue:1

    Topics: Anesthetics, Inhalation; Animals; Anti-Inflammatory Agents; Antioxidants; Bronchoalveolar Lavage Flu

2016